{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-039793","form_type":"8-K","ticker":"RNAC","cik":"0001453687","company_name":"Cartesian Therapeutics, Inc.","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.444244+00:00","generated_at":"2026-05-17T01:18:34.790043+00:00","sec_items":["5.02","5.03","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"confidence":"high","headline":"Cartesian Therapeutics Chair Carrie Cox resigns; CEO Carsten Brunn named Chairman, bylaw amended","bullets":["Carrie Cox resigned from the Board and as Chair on Oct. 29, 2025, to focus on other commitments; not related to any disagreement.","Carsten Brunn, Ph.D., CEO and Board member, appointed Chairman of the Board effective immediately.","Patrick Zenner named Lead Independent Director; Kemal Malik appointed Chairman of the Compensation Committee.","Board approved amended and restated Bylaws to incorporate references to Lead Independent Director."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-039793","json":"https://secwatch.observer/filing/0001140361-25-039793.json","markdown":"https://secwatch.observer/filing/0001140361-25-039793.md","text":"https://secwatch.observer/filing/0001140361-25-039793.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453687/000114036125039793/0001140361-25-039793-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453687/000114036125039793/ef20057980_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:18:34.790043+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}